Alzheimer Disease in the US Population

Abstract

The number of persons with AD in the US population will continue to increase unless new discoveries facilitate prevention of the disease.

Severity Distribution of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study

“…For the distribution of disease severity among AD dementia, FHS results are consistent with those reported by the Dementia UK 2007 report [6] and by CHAP [4]. Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe.…”

“…Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe. Since the Dementia UK 2007 report was based on all dementia and not AD dementia, the results in the present study are more appropriate to compare with those reported from the CHAP study [4]. The pooled estimates of mild, moderate, and severe AD dementia in the present analysis were 50.4%, 30.3%, and 19.3%, respectively, which are comparable to corresponding rates of 48%, 31%, and 21% in the CHAP study.…”

Severity Distribution of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study

“…For the distribution of disease severity among AD dementia, FHS results are consistent with those reported by the Dementia UK 2007 report [6] and by CHAP [4]. Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe.…”

“…Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe. Since the Dementia UK 2007 report was based on all dementia and not AD dementia, the results in the present study are more appropriate to compare with those reported from the CHAP study [4]. The pooled estimates of mild, moderate, and severe AD dementia in the present analysis were 50.4%, 30.3%, and 19.3%, respectively, which are comparable to corresponding rates of 48%, 31%, and 21% in the CHAP study.…”

Role of testosterone in memory impairment of Alzheimer disease induced by Streptozotocin in male rats

“…This is in accordance with other reports showed that ICV injection of STZ could induce an experimental model of sporadic AD [21]. This dose of STZ is safe and has been shown do not cause any change in the peripheral blood glucose level [22]. Thus, this protocol was used throughout this study to create animal model of sporadic AD.…”

A Longitudinal Analysis of the Lifetime Cost of Dementia

“…It is important to note that the algorithm we used to define dementia may not entirely precisely match the clinical definition of dementia. In our results, the point estimate of dementia prevalence in the MCBS sample is 6.4 percent, which is lower than found by most epidemiologic studies, which often report a prevalence rate of 10 percent or higher (Evans et al 1990;Herbert et al 2003;Plassman et al 2007). Similarly, our simulation suggests 14 percent of the cohort born between the 1920s and 1930s will develop dementia, which is close to the point estimate from ADAMS of 13.9 percent, although the ADAMS sample only includes those age 70 or older.…”

Severity Distribution of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study

“…For the distribution of disease severity among AD dementia, FHS results are consistent with those reported by the Dementia UK 2007 report [6] and by CHAP [4]. Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe.…”

“…Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe. Since the Dementia UK 2007 report was based on all dementia and not AD dementia, the results in the present study are more appropriate to compare with those reported from the CHAP study [4]. The pooled estimates of mild, moderate, and severe AD dementia in the present analysis were 50.4%, 30.3%, and 19.3%, respectively, which are comparable to corresponding rates of 48%, 31%, and 21% in the CHAP study.…”

Role of testosterone in memory impairment of Alzheimer disease induced by Streptozotocin in male rats

“…This is in accordance with other reports showed that ICV injection of STZ could induce an experimental model of sporadic AD [21]. This dose of STZ is safe and has been shown do not cause any change in the peripheral blood glucose level [22]. Thus, this protocol was used throughout this study to create animal model of sporadic AD.…”

A Longitudinal Analysis of the Lifetime Cost of Dementia

“…It is important to note that the algorithm we used to define dementia may not entirely precisely match the clinical definition of dementia. In our results, the point estimate of dementia prevalence in the MCBS sample is 6.4 percent, which is lower than found by most epidemiologic studies, which often report a prevalence rate of 10 percent or higher (Evans et al 1990;Herbert et al 2003;Plassman et al 2007). Similarly, our simulation suggests 14 percent of the cohort born between the 1920s and 1930s will develop dementia, which is close to the point estimate from ADAMS of 13.9 percent, although the ADAMS sample only includes those age 70 or older.…”

Severity Distribution of Alzheimer’s Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study

“…For the distribution of disease severity among AD dementia, FHS results are consistent with those reported by the Dementia UK 2007 report [6] and by CHAP [4]. Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe.…”

“…Across all three studies, the percentage mild was higher than moderate, and the percentage moderate was higher than severe. Since the Dementia UK 2007 report was based on all dementia and not AD dementia, the results in the present study are more appropriate to compare with those reported from the CHAP study [4]. The pooled estimates of mild, moderate, and severe AD dementia in the present analysis were 50.4%, 30.3%, and 19.3%, respectively, which are comparable to corresponding rates of 48%, 31%, and 21% in the CHAP study.…”

Role of testosterone in memory impairment of Alzheimer disease induced by Streptozotocin in male rats

“…This is in accordance with other reports showed that ICV injection of STZ could induce an experimental model of sporadic AD [21]. This dose of STZ is safe and has been shown do not cause any change in the peripheral blood glucose level [22]. Thus, this protocol was used throughout this study to create animal model of sporadic AD.…”

A Longitudinal Analysis of the Lifetime Cost of Dementia

“…It is important to note that the algorithm we used to define dementia may not entirely precisely match the clinical definition of dementia. In our results, the point estimate of dementia prevalence in the MCBS sample is 6.4 percent, which is lower than found by most epidemiologic studies, which often report a prevalence rate of 10 percent or higher (Evans et al 1990;Herbert et al 2003;Plassman et al 2007). Similarly, our simulation suggests 14 percent of the cohort born between the 1920s and 1930s will develop dementia, which is close to the point estimate from ADAMS of 13.9 percent, although the ADAMS sample only includes those age 70 or older.…”